Prognostic Stage IV Breast Cancer AJCC v8 Recruiting Phase 1 Trials for Trastuzumab deruxtecan (DB14962)

IndicationStatusPhase
DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs